Michael Peel / Financial Times:

AstraZeneca signs a deal worth up to $247M with US-based Absci to harness its AI tech for large-scale protein analysis and design an antibody to fight cancer  —  Deal with Absci is the latest between big pharma and tech companies to build new disease treatments

Michael Peel / Financial Times:

AstraZeneca signs a deal worth up to $247M with US-based Absci to harness its AI tech for large-scale protein analysis and design an antibody to fight cancer  —  Deal with Absci is the latest between big pharma and tech companies to build new disease treatments

Source: TechMeme
Source Link: http://www.techmeme.com/231203/p2#a231203p2